Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
The Secret Destinations Amex Says Will Be More Popular Than Bali by 2026- The pinch at the pump continues on
- NASA's Perseverance Mars rover could break the record for miles driven on another planet
- Most loved Public Dish: Which One Addresses Its Nation Best?
- Egypt's cafés and shops forced to close early due to Iran war
- Europe's powerful Ariane 6 rocket launches Sentinel-1D Earth-observation satellite to orbit (video)
- NASA's Artemis 2 astronauts are cruising to the moon. So why are they doing CPR tests today?
- Extravagance SUVs for Seniors: Solace, Innovation, and Security
- 21 Things You Ought to Never Tell Your Childless Companion
